The American College of Radiology® (ACR®) submitted comments to the Centers for Medicare and Medicaid Services (CMS) related to the 2024 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule that address radiology-specific issues and make specific recommendations.
CMS requested feedback on potential changes to the current packaging policy for diagnostic radiopharmaceuticals. The College recommended that CMS establish separate payment for diagnostic radiopharmaceuticals, including a per day cost threshold based on average sales price (ASP) + 6% methodology. The ACR also signed on to a coalition letter urging CMS to pay separately for these drugs, citing diminished patient access to these diagnostic tools that are vital to delivering the most appropriate treatment course.
The ACR also submitted comments related to other proposals in the rule, including the potential adoption of a new radiology-specific Hospital Outpatient Quality Reporting (OQR) Program measure, recommending that CMS take a considered approach to implementation, as well as renaming the measure.
CMS will take all comments from stakeholders into consideration and release its final rule in November. If you have questions about ACR’s HOPPS proposed rule comments, contact Kimberly Greck, ACR Senior Economic Policy Analyst.
Make America Healthy Again
President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.
Read moreScope of Practice Bills Introduced At State Legislative Level
The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.
Read moreACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint
The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.
Read more